Abstract Deadline: May 1Presenting recent advances and emerging areas of lymphoma research
Cancer Research Catalyst discusses phase I clinical trials involving immune checkpoint inhibitors presented at the AACR Annual Meeting 2018.
Early Registration Deadline: May 11Discuss the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology.
No annual dues required for Associate membership. Apply today.
Application Deadline: May 4A one-year grant of $100,000 for physician-scientists to gain experience in early-stage or late-stage clinical development at an AstraZeneca facility.
AACR, AACI Visit Capitol Hill to Thank Congress for Prioritizing Funding for Cancer Research
Short-acting Calcium Channel Blockers Were Associated With Increased Risk of Pancreatic Cancer in Postmenopausal Women
TLR9 Agonist CMP-001-Pembrolizumab Combination Shows Early Efficacy in Patients With Metastatic Melanoma Resistant to Anti-PD-1
Latest Advances in Lung Cancer Research
Advances in Malignant Lymphoma
AACR-Johnson & Johnson Lung Cancer Innovation Science Grants
Cancer Dormancy and Residual Disease